MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
Marijuana Stocks, Finance, & Investing January 22, 2021 0
MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.
Psychedelic Schools for ‘Shamans’ Are Popping Up Like Mushrooms
Marijuana Stocks, Finance, & InvestingUncategorized January 21, 2021
Even before Oregon and Washington, D.C., decriminalized medical psilocybin, the active ingredient in “magic mushrooms,” in November, a market was emerging for schools that teach mental and medical health professionals how to use psychedelics in their treatment.
Read moreThe public’s perception of the harms of magic mushrooms is in line with science — but not with the law
Marijuana Stocks, Finance, & InvestingUncategorized January 21, 2021
New research suggests that the public’s perception of the potential harms of magic mushrooms is not in line with drug laws.
Read moreWhat Will The Psychedelics Space Look Like In 2021? Experts Weigh In
Marijuana Stocks, Finance, & InvestingUncategorized January 21, 2021
In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.
Read moreMindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD
Marijuana Stocks, Finance, & InvestingUncategorized January 21, 2021
MindMed begins the first Phase 1 clinical trial testing the safety and tolerance of MDMA and LSD in combination.
Read moreTrump Grants Clemency To Marijuana Prisoners On Last Day In Office
Marijuana Stocks, Finance, & InvestingUncategorized January 21, 2021
As one of his final acts in the White House, President Trump on Wednesday announced that he has granted clemency to dozens more people with marijuana and drug convictions.
Read moreLow Tide For Psychedelic Stocks With Media, Investors Distracted
Marijuana Stocks, Finance, & InvestingUncategorized January 19, 2021
The U.S. election has become a major political circus. With investors distracted and the media focused elsewhere, psychedelic stocks are temporarily at low tide.
Read moreCYBIN Announces Upsize to Previously Announced Bought Deal Offering
Marijuana Stocks, Finance, & InvestingUncategorized January 19, 2021
Cybin’s bought deal financing has been upsized to CAD$30 million.
Read moreFrance Asks for Citizen Input on Cannabis Legalization & Related Policies
Marijuana Stocks, Finance, & InvestingUncategorized January 19, 2021
France has launched a public consultation about cannabis legalization asking citizens about their views on cannabis and what government policies people would prefer, France24 reports.
Read moreFurther Research into Psilocybin Opens New Doors for Treatment
Marijuana Stocks, Finance, & InvestingUncategorized January 18, 2021
NEW YORK, Jan. 7, 2021 /PRNewswire/ — Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.
Read more